Marta Korniyenko

Marta Korniyenko

Auto-generated profile, based on publicly available information

Marta Korniyenko

Department of Psychiatry and Psychology Hospital Clínic de Barcelona Barcelona Catalonia Spain

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2026 in Bipolar Disorders
Verified
Journal Article
Closed access
DHDiego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
GAGerard Anmella
Gerard Anmella
MPMichele De Prisco
Michele De Prisco
VOVincenzo Oliva
Vincenzo Oliva
GFGiovanna Fico
Giovanna Fico
Eduard VietaEduard Vieta
Eduard Vieta

2 July 2026 in European Psychiatry
Verified
Journal Article
Open access
MCMeritxell Gonzalez Campos
Meritxell Gonzalez Campos
GAGerard Anmella
Gerard Anmella
MPMichele De Prisco
Michele De Prisco
VOVincenzo Oliva
Vincenzo Oliva
CPClàudia Valenzuela Pascual
Clàudia Valenzuela Pascual
DHDiego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
Background: Bipolar disorder (BD) is frequently misdiagnosed as major depressive disorder (MDD), with diagnostic delays averaging 6–10 years leading to suboptimal treatment and poorer outcomes. Early identification of patients at risk for diagnostic conversion remains a critical clinical priority. We aimed to identify clinical predictors of BD conversion in a large population-based cohort and develop a clinically applicable prediction model. Methods: We conducted a retrospective cohort study using electronic health records from the Catalan PADRIS-PRESTO database (2010–2019). Patients aged ≥18 years with incident MDD diagnosed in specialized mental health services (2015–2019) were followed until BD diagnosis, death, or study end. Time-varying Cox regression addressed proportional hazards violations, with competing risks analysis accounting for mortality. Results: Among 52,001 patients (median follow-up 4.0 years), 3,958 (7.61%) converted to BD. Psychotic features emerged as the strongest predictor (HR = 3.18, 95% CI: 2.92–3.45, E-value = 5.82), with consistent effects across follow-up. Anxiety disorders showed time-varying protection (baseline HR = 0.41, 95% CI: 0.35–0.48) that attenuated over time (interaction HR = 1.30 per period). The time-varying model achieved good discrimination (C-index = 0.745). Machine learning validation confirmed predictor importance rankings (Spearman r = 0.87). Conclusions: Psychotic features during depressive episodes robustly predict BD conversion, warranting enhanced clinical monitoring. Our time-varying prediction model using routinely collected clinical data enables early risk stratification to guide diagnostic vigilance and treatment decisions.

11 March 2026 in JMIR Preprints
Verified
Preprint
Open access
CPClàudia Valenzuela Pascual
Clàudia Valenzuela Pascual
MGMarina Garriga
Marina Garriga
RBRoger Borràs
Roger Borràs
RVRuth Voltà-Solerdelcoll
Ruth Voltà-Solerdelcoll
MKMarta Korniyenko
Marta Korniyenko
DHDiego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
BACKGROUND Wearable devices allow continuous and objective collection of digital biosignals in day-to-day life. In bipolar disorder (BD), digital biosignals such as electrodermal activity (EDA) and heart rate (HR) can fluctuate depending on mood state and symptom severity, but their association with illness course remains unclear. OBJECTIVE This study investigated whether naturalistic EDA and HR profiles differ by BD illness course variables (subtype, predominant polarity, years since onset, lifetime episodes) in euthymic patients, evaluating their potential as illness-course biomarkers. METHODS For this exploratory post hoc analysis, we used data from 80 euthymic BD spectrum patients from the INTREPIBD–TIMEBASE cohort. They wore an Empatica E4 wristband for 48 hours in naturalistic settings. We evaluated the effects of four illness course variables (BD subtype, predominant polarity, years since illness onset, and number of lifetime episodes) on three biosignals collected with the E4 (EDA mean, EDA peaks per minute, and HR) with generalized additive models (GAMs). The interaction of the clinical variables with the biosignals’ circadian pattern was also tested in a second set of GAMs. All models were adjusted for age, sex, current antipsychotic use and a random effect for subjects. RESULTS 61.2% of the participants were females and the mean age was 56.9 years old. After adjusting for covariates, only years since illness onset was associated with EDA peaks per minute, with the group with more than 22 years of BD showing fewer EDA peaks than the rest (β = -0.80, SE = 0.34, p = 0.02). This difference did not remain significant after multiple comparison corrections. BD subtype, predominant polarity, and number of lifetime episodes did not predict any EDA components or HR in the main results. None of the clinical variables showed a significant interaction with EDA or HR circadian pattern. In the sensitivity analysis, years since BD onset and predominant polarity predicted EDA peaks, even after adjusting for multiple comparisons. CONCLUSIONS In euthymic BD, only illness duration showed modest EDA phasic effects after covariate adjustment, supporting digital biosignals' predominant state-dependent role. Illness-course biomarker utility appears limited, requiring longitudinal validation in larger cohorts.

11 November 2025 in Evidence-Based Nursing
Verified
Journal Article
Closed access
PDF file
MKMarta Korniyenko
Marta Korniyenko
DHDiego Hidalgo-Mazzei
Diego Hidalgo-Mazzei

4 November 2026 in JMIR Mental Health
Verified
Journal Article
Open access
CPClàudia Valenzuela Pascual
Clàudia Valenzuela Pascual
MGMarina Garriga
Marina Garriga
RBRoger Borràs
Roger Borràs
RVRuth Voltà-Solerdelcoll
Ruth Voltà-Solerdelcoll
MKMarta Korniyenko
Marta Korniyenko
DHDiego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
Background: Although bipolar disorder (BD) lacks objective biomarkers of illness progression, wearable devices enable continuous, real-world collection of physiological digital biosignals, offering a promising approach to address this gap. Measures such as electrodermal activity (EDA) and heart rate variability (HRV) fluctuate with mood state and symptom severity. Previous studies have reported reduced EDA during depressive episodes and increased HRV following symptom resolution after acute mood episodes. Furthermore, greater illness burden in BD has been associated with lower HRV, suggesting that digital biosignals may capture not only state-related changes but also aspects of illness course. Objective: This study investigated whether naturalistic EDA and heart rate (HR) profiles differ according to illness course variables in BD—including diagnosis, predominant polarity, years since onset, and lifetime number of episodes—in euthymic patients, to evaluate their potential as illness course biomarkers. Methods: This cross-sectional post hoc analysis used data from 80 euthymic patients on the BD spectrum from the INTREPIBD-TIMEBASE cohort. Participants were recruited at Hospital Clínic de Barcelona (Spain) between 2021 and 2024 and wore an Empatica E4 wristband for 48 hours in naturalistic settings. Inclusion criteria comprised a current or past DSM-5 ( Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition) diagnosis of BD confirmed by structured interview and sustained euthymia. We examined the effects of 4 illness course variables (diagnosis, predominant polarity, years since onset, and number of lifetime episodes) on 3 biosignals (mean EDA, EDA peaks per minute, and HR) using generalized additive models. Interactions between illness course variables and circadian patterns were also assessed. All models were adjusted for age, sex, and current antipsychotic use and included a participant-specific random effect. Results: Of the 80 participants, 49 (61.3%) were female; participants’ mean age was 46.9 (SD 14.1) years. After adjustment for covariates and multiple comparisons, no significant associations were observed between illness course variables and EDA or HR. In sensitivity analyses excluding patients with schizoaffective disorder (n=75), years since illness onset and predominant polarity were associated with EDA peaks per minute after multiple comparison correction. Specifically, patients with more than 22 years since illness onset had fewer EDA peaks compared with other groups (β=−1.06, 95% CI −1.71 to −0.41; P =.001). No significant interactions were found between illness course variables and circadian patterns of EDA or HR. Conclusions: To our knowledge, this is the first study to examine the association between illness course variables and EDA and HR recorded in naturalistic settings in BD. In contrast to prior findings linking illness burden with HRV, our results suggest that years since illness onset may show modest associations with phasic EDA activity. These findings indicate that digital biosignals may be more sensitive to state-related changes than to illness course characteristics, limiting their use as longitudinal biomarkers of disease progression.